Todd Clark is the President of VOI Consulting and the author of many pharmaceutical industry publications, including our latest report on Alzheimer’s disease. During nearly 20 years experience in the life sciences field, he has consulted with 11 of the top 15 drug companies, as well as leading biotech firms, investment banks and cutting-edge health technology services — advising them on market entry, clinical trial design, regulatory compliance, marketing strategy, forecasting, competitive intelligence, pricing, allocation of sales-force resources, promotional programs and more. He is a member of the pharmaceutical advisory team for the Gerson Lehman Group, has been certified as an expert witness in pharmaceutical patent litigation and is frequently quoted in industry trade publications.

Todd is a graduate of Tulane University and has an MBA from the Kellogg School of Management at Northwestern University. In addition to his duties with VOI, he has taught courses in marketing, business strategy and managerial decision making at Tulane University and Loyola University. For the latter institution, he developed a healthcare management curriculum and taught healthcare policy, payment and regulation within that program. In addition, he serves on the Business Studies Advisory Group for Tulane.